Investors in Aveanna Healthcare Holdings (NASDAQ:AVAH) have unfortunately lost 89% over the last year




  • In Business
  • 2022-12-08 12:18:46Z
  • By Simply Wall St.
 

It's not a secret that every investor will make bad investments, from time to time. But it's not unreasonable to try to avoid truly shocking capital losses. So spare a thought for the long term shareholders of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH); the share price is down a whopping 89% in the last twelve months. That'd be a striking reminder about the importance of diversification. Aveanna Healthcare Holdings hasn't been listed for long, so although we're wary of recent listings that perform poorly, it may still prove itself with time. Furthermore, it's down 62% in about a quarter. That's not much fun for holders. This could be related to the recent financial results - you can catch up on the most recent data by reading our company report. While a drop like that is definitely a body blow, money isn't as important as health and happiness.

With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.

See our latest analysis for Aveanna Healthcare Holdings

Given that Aveanna Healthcare Holdings didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. When a company doesn't make profits, we'd generally expect to see good revenue growth. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

In the last year Aveanna Healthcare Holdings saw its revenue grow by 3.8%. While that may seem decent it isn't great considering the company is still making a loss. Even so you could argue that it's surprising that the share price has tanked 89%. We'd venture this growth was too low to give holders confidence that profitability is on the horizon. But if it will make money, albeit later than previously believed, this could be an opportunity.

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

We consider it positive that insiders have made significant purchases in the last year. Even so, future earnings will be far more important to whether current shareholders make money. If you are thinking of buying or selling Aveanna Healthcare Holdings stock, you should check out this free report showing analyst profit forecasts.

A Different Perspective

We doubt Aveanna Healthcare Holdings shareholders are happy with the loss of 89% over twelve months. That falls short of the market, which lost 20%. That's disappointing, but it's worth keeping in mind that the market-wide selling wouldn't have helped. With the stock down 62% over the last three months, the market doesn't seem to believe that the company has solved all its problems. Given the relatively short history of this stock, we'd remain pretty wary until we see some strong business performance. It's always interesting to track share price performance over the longer term. But to understand Aveanna Healthcare Holdings better, we need to consider many other factors. Case in point: We've spotted 2 warning signs for Aveanna Healthcare Holdings you should be aware of.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You'll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here

COMMENTS

More Related News

The past year for Oxford Biomedica (LON:OXB) investors has not been profitable
The past year for Oxford Biomedica (LON:OXB) investors has not been profitable

Oxford Biomedica plc ( LON:OXB ) shareholders should be happy to see the share price up 26% in the last quarter. But...

DBS Group Holdings (SGX:D05) Ticks All The Boxes When It Comes To Earnings Growth
DBS Group Holdings (SGX:D05) Ticks All The Boxes When It Comes To Earnings Growth

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

TAT Technologies (NASDAQ:TATT) shareholders have endured a 41% loss from investing in the stock five years ago
TAT Technologies (NASDAQ:TATT) shareholders have endured a 41% loss from investing in the stock five years ago

TAT Technologies Ltd. ( NASDAQ:TATT ) shareholders should be happy to see the share price up 12% in the last month. But...

Investing in Intapp (NASDAQ:INTA) a year ago would have delivered you a 53% gain
Investing in Intapp (NASDAQ:INTA) a year ago would have delivered you a 53% gain

The simplest way to invest in stocks is to buy exchange traded funds. But investors can boost returns by picking...

Investors in Bicycle Therapeutics (NASDAQ:BCYC) have made a impressive return of 157% over the past three years
Investors in Bicycle Therapeutics (NASDAQ:BCYC) have made a impressive return of 157% over the past three years

It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business